LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis
about
Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient miceL(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.
P2860
LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
LAP degradation product reflec ...... patients with hepatic fibrosis
@ast
LAP degradation product reflec ...... patients with hepatic fibrosis
@en
type
label
LAP degradation product reflec ...... patients with hepatic fibrosis
@ast
LAP degradation product reflec ...... patients with hepatic fibrosis
@en
prefLabel
LAP degradation product reflec ...... patients with hepatic fibrosis
@ast
LAP degradation product reflec ...... patients with hepatic fibrosis
@en
P2093
P2860
P356
P1433
P1476
LAP degradation product reflec ...... patients with hepatic fibrosis
@en
P2093
Akiko Kirita
Daniel B Rifkin
Keisuke Nagatsuma
Mitsuko Hara
Naoshi Dohmae
Scott L Friedman
Shinji Ogawa
Shinobu Imajoh-Ohmi
Tomokazu Matsuura
Wakako Kondo
P2860
P2888
P356
10.1186/2193-1801-3-221
P577
2014-05-01T00:00:00Z
P5875
P6179
1011043492